Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology Advisor
The study’s findings suggest that palliative radiotherapy could be a viable option for managing pain in multiple myeloma patients. With a complete response rate of 48% and a partial response rate of 38%, this treatment approach shows promise.
Hematology November 6th 2023
OBR Oncology
The recent suspension of Dr. Benjamin Neel, former director of NYU’s Perlmutter Cancer Center, underscores the importance of academic integrity in the medical field. As healthcare professionals, it’s crucial to uphold the highest standards of conduct in our research.
Oncology, Medical November 6th 2023
MDLinx
The discovery that chemotherapy-induced cognitive impairment, or “chemobrain,” may be linked to an excess of calcium inside cells opens new avenues for potential therapies. This breakthrough could lead to treatments that restore cognition in patients experiencing these symptoms.
Neurology November 1st 2023
PracticeUpdate
This systematic review and meta-analysis found no significant difference in the risk of peri-implant diseases between cemented and screw-retained implant-supported prostheses.
Dentistry October 20th 2023
Journal of the American Dental Assocation (JADA)
A recent study has found that women are twice as likely as men to report not receiving advice on tobacco cessation from their dental care provider. This finding highlights the need for dentists to ensure equitable provision of information and intervention programs.
Psychiatry Advisor
Stay ahead in your practice by exploring the potential of GLP-1 Receptor Agonists (GLP-1RAs) as a new treatment option for depressive symptoms.
Psychiatry October 18th 2023